ArticleCancers2021

Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA-A Proof of Concept Study.

Falco Reissig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.